Literature DB >> 12385498

Immune response to poxvirus infections in various animals.

Scott A Smith1, Girish J Kotwal.   

Abstract

The study of infections of vertebrate animals by poxviruses has remained a dynamic area of research for the last century. The host range of poxviruses vary from extremely narrow to exceedingly broad, and they have been shown to enter their host by either the respiratory route or through the skin. The severity of infection varies dramatically from one species to another, causing anywhere from a local, self-limiting infection, to a devastating systemic disease, such as smallpox. Although the immune response to poxvirus infections are very similar to that seen in other viral infections, the poxviruses, unlike most other viruses (with the exception of Herpes viruses), are able to defend themselves. They have been shown to carry a repertoire of proteins involved in immune evasion and immune modulation. Poxviruses encode proteins involved in blocking many of the strategies employed by the host to combat viral infections; they encode for proteins that block activity of many chemokines, cytokines, serine proteases, and even complement. Traditionally, different animal models have been used to study the pathogenesis of poxvirus infections, and the characterization of virulence genes using mutant poxviruses. Additionally, new animal models are being developed to study the possible therapeutic uses many of these poxvirus immune modulating proteins might have. This review discusses the host immune response against poxvirus infections in various animals, the viral counter response to the host, and the animal models used to study poxvirus infection and immune modulating proteins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12385498     DOI: 10.1080/1040-840291046722

Source DB:  PubMed          Journal:  Crit Rev Microbiol        ISSN: 1040-841X            Impact factor:   7.624


  25 in total

1.  Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides.

Authors:  Zhenping Wang; Yuping Lai; Jamie J Bernard; Daniel T Macleod; Anna L Cogen; Bernard Moss; Anna Di Nardo
Journal:  J Immunol       Date:  2011-12-02       Impact factor: 5.422

Review 2.  Poxvirus immunomodulatory strategies: current perspectives.

Authors:  J B Johnston; Grant McFadden
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

3.  Suppression of proinflammatory signal transduction and gene expression by the dual nucleic acid binding domains of the vaccinia virus E3L proteins.

Authors:  Jeffrey O Langland; John C Kash; Victoria Carter; Matthew J Thomas; Michael G Katze; Bertram L Jacobs
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  Protective properties of vaccinia virus-based vaccines: skin scarification promotes a nonspecific immune response that protects against orthopoxvirus disease.

Authors:  Amanda D Rice; Mathew M Adams; Scott F Lindsey; Daniele M Swetnam; Brandi R Manning; Andrew J Smith; Andrew M Burrage; Greg Wallace; Amy L MacNeill; Richard W Moyer
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

5.  Vaccinia virus infection of mature dendritic cells results in activation of virus-specific naïve CD8+ T cells: a potential mechanism for direct presentation.

Authors:  Nicole L Yates; Martha A Alexander-Miller
Journal:  Virology       Date:  2006-10-20       Impact factor: 3.616

6.  HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation.

Authors:  Carla Oseroff; Ferdynand Kos; Huynh-Hoa Bui; Bjoern Peters; Valerie Pasquetto; Jean Glenn; Tara Palmore; John Sidney; David C Tscharke; Jack R Bennink; Scott Southwood; Howard M Grey; Jonathan W Yewdell; Alessandro Sette
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

7.  Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanoma.

Authors:  Howard L Kaufman; Gail Deraffele; Josephine Mitcham; Dorota Moroziewicz; Seth M Cohen; Karl S Hurst-Wicker; Ken Cheung; David S Lee; Joseph Divito; Magalese Voulo; Julie Donovan; Kate Dolan; Kelledy Manson; Dennis Panicali; Ena Wang; Heidi Hörig; Francesco M Marincola
Journal:  J Clin Invest       Date:  2005-06-02       Impact factor: 14.808

Review 8.  The evolutionary biology of poxviruses.

Authors:  Austin L Hughes; Stephanie Irausquin; Robert Friedman
Journal:  Infect Genet Evol       Date:  2009-10-13       Impact factor: 3.342

9.  Taqman real-time PCR detects Avipoxvirus DNA in blood of Hawai'i 'amakihi (Hemignathus virens).

Authors:  Margaret E M Farias; Dennis A LaPointe; Carter T Atkinson; Christopher Czerwonka; Rajesh Shrestha; Susan I Jarvi
Journal:  PLoS One       Date:  2010-05-27       Impact factor: 3.240

10.  The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model.

Authors:  Kathleen H Rubins; Lisa E Hensley; Peter B Jahrling; Adeline R Whitney; Thomas W Geisbert; John W Huggins; Art Owen; James W Leduc; Patrick O Brown; David A Relman
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.